Skip to main content
 

Substance Use Trends Across Canadian Jurisdictions, 2008–2024:
The Prevalence Interactive Chart

Select Substance
Select Metric
Select One or More Regions

Logarithmic scale used for readability


Substances Covered


This tool includes data on the following substance categories:

  • Alcohol (former alcohol use, alcohol use, mean drinks per week)
  • Tobacco (former tobacco use, tobacco use)
  • Cannabis
  • Opioids
  • Other CNS depressants
  • Cocaine
  • Other CNS stimulants
  • Any other psychoactive substances (including hallucinogens and inhalants)

Explore the Data

Interpret the 2024 estimates with caution as they are based on linear extrapolation methods using data from 2014 to 2023 and they may not reflect actual observed values.

Exposure estimates can be broken out by:

  • Province or territory
  • Year (2008-2024)
  • Sex
  • Age group (15-34, 35-64, and 65+)

Three primary metrics are available:

  • Prevalence (percentage of people using a substance)
  • Counts (number of users)
  • Standard drinks (SDs) per week (For alcohol only; this indicator shows the magnitude of alcohol consumption. One Canadian standard drink=13.45 grams of ethanol or 17.05 ml. There are three metrics based on self-reported, sales-based and total alcohol intake per person.)


Trends and Prevalence: How Estimates Were Developed

To produce new and reliable prevalence estimates of substance use trends across Canada, we combined self-reported survey data from national and regional health surveys (refer to the table), including individuals who reported having used a given substance for different frequencies within the past 12 months, regardless of whether the use was medical or non-medical (with broader criteria for some substances, including alcohol and tobacco; refer to the glossary for details). For more information about the methodology, please contact the CSUCH team.

For alcohol, the most used substance, we were able to estimate the average number of drinks consumed per day and the prevalence of binge drinking. For both alcohol and tobacco, we also estimated the percentage of the population who reported using these substances during their lifetime but not in the past 12 months.

Despite these surveys offering valuable information, they often have limitations such as missing years, underrepresented subgroups or suppressed data for smaller provinces or age groups.

To counter these limitations and produce statistically reliable estimates with reduced variance and broader coverage, we used a statistical modelling approach that incorporates:

  • Self-reported prevalence data from surveys like the:
    • Canadian Alcohol and Drug Use Monitoring Survey (CADUMS) (Health Canada, 2013),
    • Canadian Tobacco, Alcohol and Drugs Survey (CTADS) (Health Canada, 2018),
    • Canadian Alcohol and Drugs Survey (CADS) (Statistics Canada, 2021),
    • Canadian Substance Use Survey (CSUS) (Health Canada, 2025),
    • Canadian Tobacco and Nicotine Survey (CTNS) (Health Canada, 2023),
    • Canadian Cannabis Survey (CCS) (Health Canada, 2024a), and
    • Canadian Community Health Survey (CCHS) (Statistics Canada, 2023).
    • Northwest Territories Substance Use and Addictions Survey 2018, 2023 (Northwest Territories Health and Social Services, 2024).
  • Sales data for alcohol and tobacco to support estimates, where self-reporting may underestimate use (Statistics Canada, 2025a; Statistics Canada, 2025b).
  • Hospitalization and health administrative records from the Canadian Institute for Health Information (CIHI, 2025), including inpatient hospitalizations whoSlly attributable to alcohol and other drugs.
  • Police seizure data from Health Canada’s Drug Analysis Service (DAS) (Statistics Canada, 2024b).
  • Demographic and income data by jurisdiction and year (Statistics Canada, 2025c).

For example, to estimate cocaine use among men aged 35–64 in Ontario in 2020, we modelled survey data from surrounding years and regions alongside hospitalization and drug seizure records. This enabled us to fill data gaps and reduce uncertainty while collecting broader national trends over time.

Table. Data sources used to model prevalence estimates.
Substance Data Sources
Alcohol
  • CADUMS 2008–2012 (Health Canada, 2013)
  • CTADS 2013, 2015 and 2017 (Health Canada, 2018)
  • CADS 2019 (Statistics Canada, 2021)
  • CSUS 2023 (Health Canada, 2025)
  • CCHS 2008–2022 (Statistics Canada, 2023)
  • Northwest Territories Substance Use and Addictions Survey 2018, 2023 (Northwest Territories Health and Social Services, 2024)
  • Official sales of alcoholic beverages from Statistics Canada 2007/08–2023/24 (Statistics Canada, 2025a)
  • Official income data of tax filers and dependants with income in 2008–2023 and the data of population estimates in 2008–2023 from Statistics Canada (Statistics Canada, 2025c)
  • Discharge Abstract Database (DAD) 2006/2007–2023/2024 (CIHI, 2025)
Tobacco
  • CADUMS 2008–2012 (Health Canada, 2013)
  • CTADS 2013, 2015 and 2017 (Health Canada, 2018)
  • CADS 2019 (Statistics Canada, 2021)
  • CSUS 2023 (Health Canada, 2025)
  • CTNS 2020–2022 (Health Canada, 2023)
  • CCHS 2008–2022 (Statistics Canada, 2023)
  • Northwest Territories Substance Use and Addictions Survey 2018, 2023 (Northwest Territories Health and Social Services, 2024)
  • Official sales of cigarettes and fine-cut tobacco from Statistics Canada 2008–2023 (Statistics Canada, 2025b)
  • Official income data of tax filers and dependants with income in 2008–2023 and the data of population estimates in 2008–2023 from Statistics Canada (Statistics Canada, 2025c)
Cannabis
  • CCHS 2008–2022 (Statistics Canada, 2023)
  • CCS 2017–2023 (Health Canada, 2024a)
  • Official income data of tax filers and dependants with income in 2008–2023 and the data of population estimates in 2008–2023 from Statistics Canada (Statistics Canada, 2025c)
  • Northwest Territories Substance Use and Addictions Survey 2018, 2023 (Northwest Territories Health and Social Services, 2024)
  • DAD 2006/2007 to 2023/2024 (CIHI, 2025)
Opioids, other CNS depressants, cocaine, other CNS stimulants and other substances
  • CADUMS 2008–2012 (Health Canada, 2013)
  • CTADS 2013, 2015 and 2017 (Health Canada, 2018)
  • CADS 2019 (Statistics Canada, 2021)
  • CSUS 2023 (Health Canada, 2025)
  • CCHS 2008–2022 (Statistics Canada, 2023)
  • Official income data of tax filers and dependants with income in 2008–2023 and the data of population estimates in 2008–2023 from Statistics Canada (Statistics Canada, 2025c)
  • DAD 2006/2007 to 2023/2024 (CIHI, 2025)
  • DAS: Samples of illegal drugs 2012–2024 (Health Canada, 2024b)


Glossary

Term Definition
Alcohol
Former Alcohol Use Consumed at least one alcohol drink in their lifetime but not in the past 12 months
Alcohol Use Consumed alcohol drinks in the past 12 months
Sales-Based Alcohol Intake Per Person Alcohol consumed per person based on per capita sales data from Statistic Canada, expressed in SDs per week
Total Alcohol Intake Per Person Sales-based alcohol intake adjusted for unrecorded alcohol consumption using World Health Organization estimates, expressed in SD per week.
Tobacco
Former tobacco use Smoked at least 100 cigarettes in their lifetime but did not smoke daily or occasionally
Tobacco use Smoked daily or occasionally in the past 12 months
Cannabis
Cannabis Use Use of cannabis (which refers to marijuana and related products made from the cannabis plant) in the past 12 months, including for medical purposes
Opioids
Opioids Use Use of heroin and prescription opioid pain relivers such as oxycodone, hydromorphone and morphine in the past 12 months, excluding opioid replacement therapies and non-opioid analgesics
Other CNS depressants
Other CNS Depressants Use Use of any sedating or tranquillizing products like Valium, Ativan and Xanax in the past 12 months
Cocaine
Cocaine Use Use of cocaine or crack (freebase, powder, snow) in the past 12 months
Other CNS stimulants
Other CNS Stimulants Use Use of amphetamines (e.g., methamphetamines, MDMA) and prescription stimulants like Ritalin and Adderall in the past 12 months
Other substances
Other psychoactive substances use Use of hallucinogens (e.g., LSD, psilocybin), inhalants (e.g., glue, gasoline) and any other substances used to get high in the past 12 months
Metric
Prevalence Estimated percentage of individuals who reported using a substance within each demographic group across a defined period
Count Estimates number of individuals using a substance within each demographic group
Standard drink (SD) One SD = 13.45 (6) g or 17.05 ml of ethanol in Canada

Canadian Substance Use Costs and Harms Scientific Working Group. (2023). Canadian substance use costs and harms (2007–2020). Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.


Show References